Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Parsons

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Phosphatidylinositol 3-kinase inhibitors are a triple threat to ovarian cancerRamon Parsons
Seminars in Cell & Developmental Biology|June 24, 2004
Human cancer, PTEN and the PI-3 kinase pathwayRamon Parsons
Science (New York, N.Y.)|May 18, 2019
Restoring tumor suppressionRamon Parsons
Cold Spring Harbor Perspectives in Medicine|January 15, 2020
Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT OncogenesRamon Parsons
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
PTEN and cancerRamon Parsons, Laura Simpson
Cancer Discovery|May 16, 2012
mTOR inhibition, the second generation: ATP-competitive mTOR inhibitor initiates unexpected receptor tyrosine kinase-driven feedback loopMegan Keniry, Ramon Parsons
Cell Cycle (Georgetown, Tex.)|June 23, 2005
PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cellsJanusz Puc, Ramon Parsons
Trends in Cell Biology|August 30, 2003
PTEN: from pathology to biologyMaria Luisa Sulis, Ramon Parsons
Pigment Cell & Melanoma Research|May 15, 2012
PREX2, a new breed of cancer gene with too many spots?Sarah Mense, Cindy Hodakoski, Ramon Parsons
The Journal of Clinical Investigation|January 6, 2006
Is the small heat shock protein alphaB-crystallin an oncogene?Sofia K Gruvberger-Saal, Ramon Parsons
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Phosphatidylinositol 3-kinase inhibitors are a triple threat to ovarian cancerRamon Parsons
Seminars in Cell & Developmental Biology|June 24, 2004
Human cancer, PTEN and the PI-3 kinase pathwayRamon Parsons
Science (New York, N.Y.)|May 18, 2019
Restoring tumor suppressionRamon Parsons
Cold Spring Harbor Perspectives in Medicine|January 15, 2020
Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT OncogenesRamon Parsons
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
PTEN and cancerRamon Parsons, Laura Simpson
Cancer Discovery|May 16, 2012
mTOR inhibition, the second generation: ATP-competitive mTOR inhibitor initiates unexpected receptor tyrosine kinase-driven feedback loopMegan Keniry, Ramon Parsons
Cell Cycle (Georgetown, Tex.)|June 23, 2005
PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cellsJanusz Puc, Ramon Parsons
Trends in Cell Biology|August 30, 2003
PTEN: from pathology to biologyMaria Luisa Sulis, Ramon Parsons
Pigment Cell & Melanoma Research|May 15, 2012
PREX2, a new breed of cancer gene with too many spots?Sarah Mense, Cindy Hodakoski, Ramon Parsons
The Journal of Clinical Investigation|January 6, 2006
Is the small heat shock protein alphaB-crystallin an oncogene?Sofia K Gruvberger-Saal, Ramon Parsons
Pageof 8